$3.69
-0.03[-0.81%]
At close: Apr 24
$3.69
0[0.00%]
After Hours: 4:00PM EDT
Harvard Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Harvard Bioscience using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | HBIO | Q1 | $0.06 | $0.02 | — | — | $29.98M | $25.79M | — | — | Get Alert |
03/07/2024 | AM | HBIO | Q4 | $0.04 | $0.05 | $0.04 | -20.00% | $28.43M | $29.11M | $28.15M | -3.29% | Get Alert |
11/07/2023 | AM | HBIO | Q3 | -$0.01 | $0.04 | $0.01 | -75.00% | $26.92M | $28.02M | $25.36M | -9.48% | Get Alert |
08/08/2023 | AM | HBIO | Q2 | $0.05 | $0.05 | $0.04 | -20.00% | $29.21M | $29.50M | $28.76M | -2.51% | Get Alert |
04/25/2023 | AM | HBIO | Q1 | $0.04 | $0.05 | $0.06 | 20.00% | $28.78M | $28.85M | $29.98M | 3.90% | Get Alert |
03/09/2023 | AM | HBIO | Q4 | $0.08 | $0.03 | $0.04 | 33.33% | $33.05M | $30.33M | $28.43M | -6.27% | Get Alert |
11/08/2022 | PM | HBIO | Q3 | $0.06 | $0.07 | -$0.01 | -114.29% | $29.66M | $28.89M | $26.92M | -6.81% | Get Alert |
08/03/2022 | PM | HBIO | Q2 | $0.06 | $0.06 | $0.05 | -16.67% | $29.20M | $30.49M | $29.21M | -4.20% | Get Alert |
05/04/2022 | AM | HBIO | Q1 | $0.05 | $0.05 | $0.04 | -20.00% | $26.99M | $28.77M | $28.78M | 0.03% | Get Alert |
03/08/2022 | AM | HBIO | Q4 | $0.08 | $0.10 | $0.08 | -20.00% | $30.98M | $32.96M | $33.05M | 0.29% | Get Alert |
11/03/2021 | AM | HBIO | Q3 | $0.04 | $0.06 | $0.06 | 0.00% | $24.04M | $27.91M | $29.66M | 6.28% | Get Alert |
08/05/2021 | AM | HBIO | Q2 | $0.05 | $0.06 | $0.06 | 0.00% | $23.31M | $27.67M | $29.20M | 5.52% | Get Alert |
05/06/2021 | AM | HBIO | Q1 | -$0.01 | $0.03 | $0.05 | 66.67% | $23.77M | $25.73M | $26.99M | 4.89% | Get Alert |
03/10/2021 | AM | HBIO | Q4 | $0.08 | $0.06 | $0.08 | 33.33% | $30.97M | $27.13M | $30.98M | 14.21% | Get Alert |
11/05/2020 | AM | HBIO | Q3 | $0.04 | $0.03 | $0.04 | 33.33% | $27.42M | $24.05M | $24.04M | -0.05% | Get Alert |
08/05/2020 | AM | HBIO | Q2 | $0.04 | -$0.03 | $0.05 | 266.67% | $29.58M | $22.19M | $23.31M | 5.04% | Get Alert |
05/05/2020 | AM | HBIO | Q1 | $0.02 | $0.03 | -$0.01 | -133.33% | $28.20M | $27.87M | $23.77M | -14.71% | Get Alert |
02/26/2020 | AM | HBIO | Q4 | $0.07 | $0.09 | $0.08 | -11.11% | $33.94M | $31.80M | $30.97M | -2.60% | Get Alert |
11/05/2019 | PM | HBIO | Q3 | $0.04 | $0.05 | $0.04 | -20.00% | $28.71M | $28.67M | $27.42M | -4.37% | Get Alert |
Harvard Bioscience (HBIO) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
The Actual EPS was $0.04, which missed the estimate of $0.05.
The Actual Revenue was $28.2M, which missed the estimate of $29.1M.
Browse earnings estimates, EPS, and revenue on all stocks.